Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
Conditions
Interventions
Intervention1: Kabasura kudineer: Siddha medicine
30 â?? 60 ml twice daily orally
Control Intervention1: Zinc and Vitamin C: Zinc -100 mg, Vit C â?? 60000 IU twice daily orally
Sponsors
Dean Government Theni Medical College
Director General
Eligibility
Inclusion criteria
Inclusion criteria: 1.Laboratory confirmed COVID-19 without symptoms 2.Consenting to participate in the study and sign the informed consent
Exclusion criteria
Exclusion criteria: 1.Patient with co morbid conditions like DM, HT and BA. 2.Patients with severe primary respiratory disease or other pathogenic microbial pneumonia that needs to be identified with COVID-19. 3.Pregnant and mothers those who have a pregnancy plan. 4.Patients with other systemic malignant diseases such as malignant tumors, mental illnesses, etc., which the researchers consider unsuitable for participation in the study. 5.People who have been allergic to Siddha medicine or intolerant to taking medicine. 6.Patients participating in other COVID-19 clinical trials.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.Reduction in incidence of clinical symptoms like fever, cough and breathlessness. 2.Negative conversion of SARS-CoV-2 by 14 days 3.Reduction in Viral load of SARS-CoV-2 at the end of treatment (0, 7, 14 days) 4.Examine the levels of immune markers and inflammatory markers (IgG, IgM, IgA, Th1 (TNF-Alfa, IFN-gamma, IL2) Th2 (IL6, IL10) at the end of treatment (0, 7, 14 days) Timepoint: 14 days | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.Reduction in incidence of complications. 2.Reduction of in hospital time. 3.Laboratory markers 4.Adverse events/effects Timepoint: 14 days | — |
Countries
India
Contacts
Public ContactDr C Anbarasi
Government Theni Medical College and Hospital
Outcome results
None listed